Half-year report · Q2

Period2024-09-01 → 2025-02-28
Filed2025-04-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥14.8bn2024-09-01 → 2025-02-28Cons.Net sales
Revenue¥28.5bn2023-09-01 → 2024-08-31Cons.Net sales (5-year summary)
Revenue¥13.9bn2023-09-01 → 2024-02-29Cons.Net sales
Operating income¥4.2bn2024-09-01 → 2025-02-28Cons.Operating income
Operating income¥4.2bn2023-09-01 → 2024-02-29Cons.Operating income
Ordinary income¥4.3bn2024-09-01 → 2025-02-28Cons.Ordinary income
Ordinary income¥8.5bn2023-09-01 → 2024-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.6bn2023-09-01 → 2024-02-29Cons.Ordinary income
Profit before tax¥4.3bn2024-09-01 → 2025-02-28Cons.Income before income taxes
Profit before tax¥4.5bn2023-09-01 → 2024-02-29Cons.Income before income taxes
Net income (owners)¥2.9bn2024-09-01 → 2025-02-28Cons.Profit loss attributable to owners of parent
Net income (owners)¥6.3bn2023-09-01 → 2024-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥3.2bn2023-09-01 → 2024-02-29Cons.Profit loss attributable to owners of parent
Net income¥2.9bn2024-09-01 → 2025-02-28Cons.Profit loss
Net income¥3.2bn2023-09-01 → 2024-02-29Cons.Profit loss
Total assets¥58.3bnat 2025-02-28Cons.Assets
Total assets¥57.2bnat 2024-08-31Cons.Assets
Total assets¥56.2bnat 2024-02-29Cons.Total assets (5-year summary)
Total liabilities¥4.9bnat 2025-02-28Cons.Liabilities
Total liabilities¥4.8bnat 2024-08-31Cons.Liabilities
Net assets / equity¥53.4bnat 2025-02-28Cons.Net assets
Net assets / equity¥52.3bnat 2024-08-31Cons.Net assets
Net assets / equity¥51.6bnat 2024-02-29Cons.Net assets (5-year summary)
Cash and deposits¥18.3bnat 2025-02-28Cons.Cash and deposits
Cash and deposits¥21.6bnat 2024-08-31Cons.Cash and deposits
Cash & equivalents¥17.5bnat 2025-02-28Cons.Cash and cash equivalents
Cash & equivalents¥21.0bnat 2024-08-31Cons.Cash and cash equivalents
Cash & equivalents¥22.7bnat 2024-02-29Cons.Cash and cash equivalents
Cash & equivalents¥23.8bnat 2023-08-31dCons.Cash and cash equivalents
Operating cash flow¥3.0bn2024-09-01 → 2025-02-28Cons.Net cash provided by used in operating activities
Operating cash flow¥7.8bn2023-09-01 → 2024-08-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥3.6bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.6bn2024-09-01 → 2025-02-28Cons.Net cash provided by used in investment activities
Investing cash flow−¥6.6bn2023-09-01 → 2024-08-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥3.1bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in investment activities
Financing cash flow−¥2.3bn2024-09-01 → 2025-02-28Cons.Net cash provided by used in financing activities
Financing cash flow−¥3.7bn2023-09-01 → 2024-08-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥2.1bn2023-09-01 → 2024-02-29Cons.Net cash provided by used in financing activities
EPS (basic)¥29.852024-09-01 → 2025-02-28Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥63.822023-09-01 → 2024-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥32.412023-09-01 → 2024-02-29Cons.Basic earnings loss per share (5-year summary)
Equity ratio91.6%at 2025-02-28Cons.Equity to asset ratio (5-year summary)
Equity ratio91.5%at 2024-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio91.8%at 2024-02-29Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 32
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-09-01 → 2025-02-28¥0
Reconciling Itemsreconcilingrevenue intersegment2024-09-01 → 2025-02-28¥0
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue2024-09-01 → 2025-02-28¥4.5bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue external2024-09-01 → 2025-02-28¥4.5bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentsegment profit2024-09-01 → 2025-02-28¥460m
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue2024-09-01 → 2025-02-28¥5.6bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue external2024-09-01 → 2025-02-28¥5.6bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue intersegment2024-09-01 → 2025-02-28¥0
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentsegment profit2024-09-01 → 2025-02-28¥2.1bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue2024-09-01 → 2025-02-28¥4.7bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue external2024-09-01 → 2025-02-28¥4.7bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentsegment profit2024-09-01 → 2025-02-28¥1.6bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-09-01 → 2025-02-28¥14.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-09-01 → 2025-02-28¥14.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-09-01 → 2025-02-28¥0
Total Of Reportable Segments And Otherssegment totalsegment profit2024-09-01 → 2025-02-28¥4.2bn
Reconciling Itemsreconcilingrevenue2023-09-01 → 2024-02-29¥0
Reconciling Itemsreconcilingrevenue intersegment2023-09-01 → 2024-02-29¥0
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue2023-09-01 → 2024-02-29¥5.1bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentrevenue external2023-09-01 → 2024-02-29¥5.1bn
jpcrp040300-q2r_E02340-000Dentalreportable segmentsegment profit2023-09-01 → 2024-02-29¥1.0bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue2023-09-01 → 2024-02-29¥5.0bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue external2023-09-01 → 2024-02-29¥5.0bn
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentrevenue intersegment2023-09-01 → 2024-02-29¥0
jpcrp040300-q2r_E02340-000Eyeless Needlereportable segmentsegment profit2023-09-01 → 2024-02-29¥1.9bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue2023-09-01 → 2024-02-29¥3.8bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentrevenue external2023-09-01 → 2024-02-29¥3.8bn
jpcrp040300-q2r_E02340-000Surgicalreportable segmentsegment profit2023-09-01 → 2024-02-29¥1.2bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-09-01 → 2024-02-29¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-09-01 → 2024-02-29¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-09-01 → 2024-02-29¥0
Total Of Reportable Segments And Otherssegment totalsegment profit2023-09-01 → 2024-02-29¥4.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 507
ItemContextValueUnit
Interest expenses paid ope cf fin cfPrior1YTDDuration-0JPY
Interest expenses paid ope cf fin cfCurrentYTDDuration-1000000JPY
Income taxes paid ope cfPrior1YTDDuration-1156000000JPY
Income taxes paid ope cfCurrentYTDDuration-1046000000JPY
Net cash provided by used in operating activitiesPrior1YTDDuration3625000000JPY
Net cash provided by used in operating activitiesCurrentYTDDuration3005000000JPY
Payments into time deposits inv cfPrior1YTDDuration-438000000JPY
Payments into time deposits inv cfCurrentYTDDuration-214000000JPY
Proceeds from withdrawal of time deposits inv cfPrior1YTDDuration1251000000JPY
Proceeds from withdrawal of time deposits inv cfCurrentYTDDuration14000000JPY
Purchase of property plant and equipment inv cfPrior1YTDDuration-3803000000JPY
Purchase of property plant and equipment inv cfCurrentYTDDuration-4272000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1YTDDuration7000000JPY
Proceeds from sales of property plant and equipment inv cfCurrentYTDDuration16000000JPY
Purchase of intangible assets inv cfPrior1YTDDuration-108000000JPY
Purchase of intangible assets inv cfCurrentYTDDuration-83000000JPY
Purchase of investment securities inv cfPrior1YTDDuration-JPY
Purchase of investment securities inv cfCurrentYTDDuration-50000000JPY
Proceeds from distribution of investments in business partnership inv cfPrior1YTDDuration2000000JPY
Proceeds from distribution of investments in business partnership inv cfCurrentYTDDuration10000000JPY
Purchase of insurance funds inv cfPrior1YTDDuration-1000000JPY
Purchase of insurance funds inv cfCurrentYTDDuration-1000000JPY
Other net inv cfPrior1YTDDuration1000000JPY
Other net inv cfCurrentYTDDuration-0JPY
Net cash provided by used in investment activitiesPrior1YTDDuration-3088000000JPY
Net cash provided by used in investment activitiesCurrentYTDDuration-4579000000JPY
Repayments of lease obligations fin cfPrior1YTDDuration-29000000JPY
Repayments of lease obligations fin cfCurrentYTDDuration-25000000JPY
Purchase of treasury stock fin cfPrior1YTDDuration-0JPY
Purchase of treasury stock fin cfCurrentYTDDuration-JPY
Cash dividends paid fin cfPrior1YTDDuration-2068000000JPY
Cash dividends paid fin cfCurrentYTDDuration-2266000000JPY
Net cash provided by used in financing activitiesPrior1YTDDuration-2097000000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration-2292000000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration439000000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration333000000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-1120000000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-3532000000JPY
Cash and cash equivalentsPrior2YearInstant23798000000JPY
Cash and cash equivalentsPrior1YearInstant21017000000JPY
Cash and cash equivalentsPrior1QuarterInstant22677000000JPY
Cash and cash equivalentsCurrentQuarterInstant17485000000JPY
Salaries and allowances sgaPrior1YTDDuration998000000JPY
Salaries and allowances sgaCurrentYTDDuration1431000000JPY
Provision for bonuses sgaPrior1YTDDuration254000000JPY
Provision for bonuses sgaCurrentYTDDuration154000000JPY
Retirement benefit expenses sgaPrior1YTDDuration31000000JPY
Retirement benefit expenses sgaCurrentYTDDuration35000000JPY
Research and development expenses sgaPrior1YTDDuration1125000000JPY
Research and development expenses sgaCurrentYTDDuration1311000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-08-31pass rounding
balance sheet identityconsolidated 2025-02-28pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-08-31pass
statement vs summary · net assetsconsolidated 2025-02-28pass
statement vs summary · net income attributable to parentconsolidated 2023-09-01/2024-02-29pass
statement vs summary · net income attributable to parentconsolidated 2024-09-01/2025-02-28pass
statement vs summary · operating cash flowconsolidated 2023-09-01/2024-02-29pass
statement vs summary · operating cash flowconsolidated 2024-09-01/2025-02-28pass
statement vs summary · revenueconsolidated 2023-09-01/2024-02-29pass
statement vs summary · revenueconsolidated 2024-09-01/2025-02-28pass
statement vs summary · total assetsconsolidated 2024-08-31pass
statement vs summary · total assetsconsolidated 2025-02-28pass